News Releases

Moffitt Study Identifies Immune Response That May Stop Breast Cancer from Spreading

Targeting dormant cancer cells may hold the key to long-term survival

Moffitt Cancer Center and 1ST Biotherapeutics Announce Strategic Alliance To Transform Cancer Treatment

The five-year partnership will focus on developing novel therapies, including the promising FB849 HPK1 inhibitor

H. Lee Moffitt Named Outstanding Citizen of the Year

Moffitt Cancer Center founder has built a legacy spanning 40 years and counting

Moffitt Cancer Center Named a 2025 Women’s Choice Award Winner for Best Hospitals

The cancer center is recognized for best cancer care and mammogram imaging

Moffitt’s Magnolia Ball Raises More Than $8 Million for Cancer Research

Gala has raised more than $50 million over the past 30 years

Pickleball Program Boosts Health and Wellness for Cancer Survivors, Moffitt Study Finds

The YMCA-based initiative enhances physical function and social support for participants

Moffitt Study Finds Key Biomarker to Predict KRASG12C Inhibitor Effectiveness in Lung Cancer

New research reveals a potential method to identify which patients with KRAS-mutant lung cancer may benefit from targeted treatments

Moffitt Cancer Center Is First Health System in Tampa Bay Area To Receive Proton Therapy System for Cancer Treatment

IBA’s Proteus®ONE, arriving in February, will be the most advanced in the Tampa Bay area

Moffitt Study Shows AI Boosts Efficacy of Cancer Treatment, But Doctors Remain Key

Study highlights how collaboration between AI and human judgment improves radiotherapy outcomes

Moffitt Research Advocates for Routine Brain MRI Screening in Asymptomatic Late Stage Breast Cancer Patients

New study shows brain metastasis is more common than previously thought, regardless of breast cancer subtype

Moffitt Study Shows How Genomic Tests Could Help Treat Prostate Cancer More Effectively

Study finds genomic tests could influence risk assessment and treatment decisions for patients with early stage prostate cancer

Moffitt Cancer Center Named a Best and Brightest Company to Work For in the Nation

The cancer center has been recognized on the list for nine consecutive years

Moffitt Cancer Center and Cryoport Announce Strategic Collaboration

Cryoport’s CRYOGENE will provide Moffitt with state-of-the-art biorepository services

Tiffany Carson, Ph.D., Elected as Fellow in the Academy of Behavioral Medicine Research

Carson will be honored at the organization’s annual meeting in June